151
Participants
Start Date
June 30, 2015
Primary Completion Date
December 31, 2018
Study Completion Date
May 31, 2019
XR-NTX
Monthly injections of XR-NTX will be administered to participants assigned to either the XR-NTX or XR-NTX+PN groups.
XR-NTX+PN
In addition to long-acting naltrexone (XR-NTX), participants assigned to the XR-NTX+PN condition will meet regularly with a patient navigator to assist in accessing psychosocial services when released from jail.
ETAU
Participants assigned to the ETAU group will receive drug education.
University of New Mexico Center on Alcoholism, Substance Abuse and Addictions, Albuquerque
Collaborators (1)
Alkermes, Inc.
INDUSTRY
University of California, Los Angeles
OTHER